Search results for "Neutro"
showing 10 items of 2997 documents
A measurement of the neutron to 199Hg magnetic moment ratio
2014
The neutron gyromagnetic ratio has been measured relative to that of the 199Hg atom with an uncertainty of 0.8 ppm. We employed an apparatus where ultracold neutrons and mercury atoms are stored in the same volume and report the result γn/γHg=3.8424574(30).
Low-Intensity Neutron Emission from TiDx Samples Under Nonequilibrium Conditions
2001
Several experiments were performed that loaded titanium samples with deuterium from the gas phase, changed the temperature of the samples over a wide range, and monitored the neutron emission. Neutron emissions in very low intensity bursts, still significantly above the background, were recorded, revealing that low-energy nuclear reactions in condensed matter can be produced at a very low rate, which occasionally can be high enough to become detectable.
Beta-Decay Half-Lives and Neutron-Emission Probabilities of Very Neutron-Rich Y to Tc Isotopes
1996
Neutron-rich {sub 39}Y to {sub 43}Tc isotopes have been produced by fission of uranium with a 50MeV H{sub 2}{sup +} beam. Beta-decay half-lives, delayed neutron-emission probabilities, and production yields have been measured and compared with theory. Beta decay of 4 new isotopes is reported, and the {beta}-delayed neutron-emission mode has been discovered for 12 isotopes of the elements niobium and technetium. The results compared to quasiparticle random phase approximation predictions indicate the increasing importance of fast {beta} transitions to high-lying states of nuclei with large neutron excess. {copyright} {ital 1996 The American Physical Society.}
Search for Neutrons as Evidence of Cold Fusion
1992
In this paper investigations performed at the University of Palermo in an attempt to reproduce the cold fusion experiment are reported. The search was devoted to detecting neutron emission from palladium electrodes electrolytically charged with deuterium. In no test was neutron emission significantly over the background observed, either in bursts or continuous. Results of a few tests are reported. For the more sensitive test, an upper limit for D(d,n) cold fusion (at 98% confidence level) of {lambda}{sub f} {lt} 3.6 {times} 10{sup {minus}24} fusion/s {center dot} d-d pair is determined.
Dose calculation in biological samples in a mixed neutron-gamma field at the TRIGA reactor of the University of Mainz
2010
To establish Boron Neutron Capture Therapy (BNCT) for non-resectable liver metastases and for in vitro experiments at the TRIGA Mark II reactor at the University of Mainz, Germany, it is necessary to have a reliable dose monitoring system. The in vitro experiments are used to determine the relative biological effectiveness (RBE) of liver and cancer cells in our mixed neutron and gamma fi eld. We work with alanine detectors in combination with Monte Carlo simulations, where we can measure and characterize the dose. To verify our calculations we perform neutron fl ux measurements using gold foil activation and pin-diodes . Material and methods . When L- α -alanine is irradiated with ionizing …
Cisplatin plus weekly vinorelbine versus cisplatin plus vinorelbine on days 1 and 8 in advanced non-small cell lung cancer: a prospective randomized …
2008
Summary Purpose A phase III randomized trial was carried out to compare two schedules of the vinorelbine (VNR)–cisplatin (CDDP) regimen in patients with locally advanced unresectable poor prognosis stage IIIB or metastatic stage IV non-small cell lung cancer. The primary endpoints were overall survival (OS) and analysis of toxicity, while secondary endpoints included response rates, time-to-progression (TTP) and quality of life (QoL). Patients and methods Eligible patients were randomized to receive: (a) VNR 25 mg/m 2 on day 1, 8 and 15 plus CDDP 100 mg/m 2 on day 1 every 4 weeks or (b) VNR 30 mg/m 2 on day 1 and 8 plus CDDP 80 mg/m 2 on day 1 every 3 weeks. All patients were chemotherapy-n…
Study of the response of phenol compounds exposed to thermal neutrons beams for Electron Paramagnetic Resonance dosimetry
2015
Abstract This paper reports the results regarding a new organic compound (IRGANOX ® 1076 phenols) with and without low content (5% by weight) of gadolinium oxide (Gd 2 O 3 ) for Electron Paramagnetic Resonance (EPR) dosimetry of neutron beams. The dependence of EPR signal as function of neutron dose was investigated in the fluence range studied between 10 11 cm −2 to 10 14 cm −2 . We evaluated also the effect of gadolinium on 60 Co gamma photon sensitivity of this organic compound. Our analysis showed that a low concentration of gadolinium oxide (of the order of 5% of the total mass of the dosimeter) can enhance the thermal neutron sensitivity more than 10 times with a small reduction of …
EPR DOSIMETRY IN A MIXED NEUTRON AND GAMMA RADIATION FIELD
2004
Suitability of Electron Paramagnetic Resonance (EPR) spectroscopy for criticality dosimetry was evaluated for tooth enamel, mannose and alanine pellets during the 'international intercomparison of criticality dosimetry techniques' at the SILENE reactor held in Valduc in June 2002, France. These three materials were irradiated in neutron and gamma-ray fields of various relative intensities and spectral distributions in order to evaluate their neutron sensitivity. The neutron response was found to be around 10% for tooth enamel, 45% for mannose and between 40 and 90% for alanine pellets according their type. According to the IAEA recommendations on the early estimate of criticality accident a…
closo-borane conjugated regulatory peptides retain high biological affinity: synthesis of closo-borane conjugated Tyr(3)-octreotate derivatives for B…
2008
Despite the improvements in cancer therapy during the past years, high-grade gliomas and many other types of cancer are still extremely resistant to current forms of therapy. Boron neutron capture therapy (BNCT) provides a promising way to destroy cancer cells without damaging healthy tissue. However, BNCT in practice is still limited due to the lack of boron-containing compounds that selectively deliver boron to cancer cells. Since many neuroendocrine tumors show an overexpression of the somatostatin receptor, it was our aim to synthesize compounds that contain a large number of boron atoms and still show high affinity toward this transmembrane receptor. The synthetic peptide Tyr (3)-octre…
Receptor-mediated uptake of boron-rich neuropeptide y analogues for boron neutron capture therapy.
2014
Peptidic ligands selectively targeting distinct G protein-coupled receptors that are highly expressed in tumor tissue represent a promising approach in drug delivery. Receptor-preferring analogues of neuropeptide Y (NPY) bind and activate the human Y1 receptor subtype (hY1 receptor), which is found in 90% of breast cancer tissue and in all breast-cancer-derived metastases. Herein, novel highly boron-loaded Y1 -receptor-preferring peptide analogues are described as smart shuttle systems for carbaboranes as (10) B-containing moieties. Various positions in the peptide were screened for their susceptibility to carbaborane modification, and the most promising positions were chosen to create a mu…